Paul Hastings Represents Applera Corporation in its $195 Million Acquisition of Berkeley HeartLab

September 10, 2007

Paul Hastings Represents Applera Corporation in its $195 Million Acquisition of Berkeley HeartLab

San Diego, CA (September 10, 2007) – Paul, Hastings, Janofsky & Walker LLP, a leading international law firm, announced today that the firm represented the Celera Group of Applera Corporation in its agreement to acquire Berkeley HeartLab Inc, a cardiovascular healthcare company. The deal is valued at approximately $195 million.

Under the agreement, California-based Berkeley Heartlab will operate as a business unit of Celera.

Mergers & acquisitions partner Deyan Spiridonov led the Paul Hastings team, which included associates Teri O’Brien and Tamara Sampsell. Healthcare partner James Owens advised Applera on regulatory matters for the acquisition.

About Applera Corporation: Applera Corporation is a life sciences company with a mission to develop breakthrough research technologies, diagnostic products, and drugs to improve the human condition. Applera Corporation consists of two business groups - the Applied Biosystems group and the Celera group.

Paul, Hastings, Janofsky & Walker LLP, founded in 1951, is a leading international law firm with over 1,200 attorneys in 18 offices. The firm serves a diverse client base including many of the leading global financial institutions and Fortune 500 companies and offers deep capabilities in capital markets, finance and restructuring, intellectual property, international arbitration and dispute resolution, investment management, labor and employment, mergers and acquisitions, private equity, product liability, project finance, real estate, securities litigation and tax advisory services. For additional information, please visit our website at www.paulhastings.com.